Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global ...
Type 1 diabetes wears many faces—an elusive autoimmune disease, a metabolic mess, a chronic condition that requires lifelong ...
Automakers are increasingly collaborating with coatings manufacturers to develop lightweight, high-performance coatings that ...
Abbott Laboratories ( NYSE: ABT) Q3 2025 Earnings Call October 15, 2025 9:00 AM EDT ...
It’s that time of year again—the Colors of the Year for 2026 are starting to roll out. From a cool, calm, and collected shade of green to a rich, cozy red that feels instantly inviting, this year’s ...